Please select the option that best describes you:

Given improved BFS from the phase III FLAME trial, do you recommend focal SIB up to 95 Gy for unfavorable and high risk prostate patients?  



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Beth Israel Deaconess Medical Center/Harvard Medical School
First, I have NO financial interests to disclose. ...
Radiation Oncologist at Via Christi Health
Didn't you present your 10 year PSA control data a...
Radiation Oncologist at Virginia Commonwealth University Medical Center
Sorry, no. We’ve never published on this app...
Radiation Oncologist at START Center for Cancer Care
ACTUALLY, there is a patterns of failure study fro...
Sign in or Register to read more